Liang Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Liang Yang has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
Shuyi Yang
Department of Radiology Zhongshan Hospital Fudan University Shanghai 200032 P. R. China
3 shared publicationsWei Cui
Department of Orthopedics Wuxi Ninth People's Hospital Affiliated to Soochow University Wuxi 214000 P. R. China
3 shared publications- Xiaodong Guo
Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3 shared publications Ismat Ullah
CAS Key Laboratory of Nano‐Bio Interface Division of Nanobiomedicine Suzhou Institute of Nano‐Tech and Nano‐Bionics Chinese Academy of Sciences Suzhou 215123 P. R. China
2 shared publicationsKeda Yu
Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science And Technology, Wuhan 430022, People’s Republic of China
2 shared publicationsShengyang Jin
Department of Orthopaedics The First Affiliated Hospital of Soochow University Suzhou 215006 P. R. China
2 shared publications
Latest Publications
- 16 June 2025
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (22) , e2500921
Multifunctional Sr 2+ /Zn 2+ Co‐Doped Mesoporous Silica Nanoparticles in Injectable Hydrogel for Ameliorating Osteoporotic Osseointegration
Developing advanced biomaterials with controllable nanostructures and biological multifunctionality is highly promising in biomedical fields. In this study, novel Sr 2+ /Zn 2+ co‐doped mesoporous silica nanoparticles (MSNs) are fabricated using a designated substitution and etching method. The obtained SrZn‐MSNs possess unique hollow mesoporous structures, round spherical morphology, high specific surface areas, and suitable pore sizes. On this basis, gelatin methacrylate is combined with SrZn‐MSNs to construct injectable photo‐crosslinked hydrogels characterized by desired 3D interconnected porous structure, rough micro‐surface topography, sustained Sr/Zn ions releasing, improved biomineralization and mechanical properties. These satisfactory properties allow SrZn‐MSNs to fully exert their bioactivity in composite hydrogels, efficiently ameliorating osteoporotic osseointegration around Ti alloys without drug loading. Direct cell culture on composite hydrogels further confirms the superior biological multifunctionality of SrZn‐MSNs to positively manipulate the coupling of immunoregulation‐osteogenesis‐angiogenesis, depending on the synergetic actions of bioactive Sr 2+ /Zn 2+ . Furthermore, the underlying molecular mechanism responsible for enhanced osteogenesis of SrZn‐MSNs is clarified to be the upregulated PI3K‐AKT pathway, mainly mediated by activated integrin (Itgβ8, Itgα4) and toll‐like receptor (Tlr2) signaling. These findings throw new insights into the fabrication of novel SrZn‐MSNs and highlight its superior biological multifunctionality and osteogenic mechanism, thus may providing a new practical strategy for bone healing.
- 16 June 2025
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (22) , e2500921
Multifunctional Sr 2+ /Zn 2+ Co‐Doped Mesoporous Silica Nanoparticles in Injectable Hydrogel for Ameliorating Osteoporotic Osseointegration
Developing advanced biomaterials with controllable nanostructures and biological multifunctionality is highly promising in biomedical fields. In this study, novel Sr 2+ /Zn 2+ co‐doped mesoporous silica nanoparticles (MSNs) are fabricated using a designated substitution and etching method. The obtained SrZn‐MSNs possess unique hollow mesoporous structures, round spherical morphology, high specific surface areas, and suitable pore sizes. On this basis, gelatin methacrylate is combined with SrZn‐MSNs to construct injectable photo‐crosslinked hydrogels characterized by desired 3D interconnected porous structure, rough micro‐surface topography, sustained Sr/Zn ions releasing, improved biomineralization and mechanical properties. These satisfactory properties allow SrZn‐MSNs to fully exert their bioactivity in composite hydrogels, efficiently ameliorating osteoporotic osseointegration around Ti alloys without drug loading. Direct cell culture on composite hydrogels further confirms the superior biological multifunctionality of SrZn‐MSNs to positively manipulate the coupling of immunoregulation‐osteogenesis‐angiogenesis, depending on the synergetic actions of bioactive Sr 2+ /Zn 2+ . Furthermore, the underlying molecular mechanism responsible for enhanced osteogenesis of SrZn‐MSNs is clarified to be the upregulated PI3K‐AKT pathway, mainly mediated by activated integrin (Itgβ8, Itgα4) and toll‐like receptor (Tlr2) signaling. These findings throw new insights into the fabrication of novel SrZn‐MSNs and highlight its superior biological multifunctionality and osteogenic mechanism, thus may providing a new practical strategy for bone healing.
- Open Access
- 31 December 2024
- Published by Wiley in Advanced Science
- Vol. 12 (8) , e2411602
Chirality‐Induced Hydroxyapatite Manipulates Enantioselective Bone‐Implant Interactions Toward Ameliorative Osteoporotic Osseointegration
Inspired by the fundamental attribute of chirality in nature, chiral‐engineered biomaterials now represent a groundbreaking frontier in biomedical fields. However, the integration of chirality within inorganic materials remains a critical challenge and developments of chirality‐induced bionic bone implants are still in infancy. In this view, novel chiral hydroxyapatite (CHA) coated Ti alloys are successfully synthesized by a sophisticated chiral molecule‐induced self‐assembly method for the first time. The obtained samples are characterized by stereospecific L‐/D‐/Rac‐chiral hierarchical morphology, nanotopography rough surfaces, improved hydrophilicity, and bioactivity. Following implantation into rat femoral condyle defects, the distinct stereospecific chiral hierarchical structures exhibit highly enantioselective bone‐implants interactions, wherein the left‐handed chirality of L‐CHA strongly promotes osteoporotic osseointegration and vice versa for right‐handed chirality of D‐CHA. Consistently, in vitro assays further validate the superior enantiomer‐dependent osteoporotic osseointegration ability of L‐CHA, mainly by manipulating desired immunomodulation coupled with enhanced neurogenesis, angiogenesis, and osteogenesis. Moreover, as analyzed by transcriptomic RNA‐seq, a new discovery of down‐regulated IL‐17 signaling pathway is considered predominately responsible for the desired immunomodulation ability of L‐CHA. These results provide new insights into biological multifunctionality and mechanism underlying L‐chirality's roles for bone healing, thus may inspiring developments of new generation of chiral biomaterials.
- 31 December 2024
- Published by Wiley in Advanced Science
- Vol. 12 (8) , e2411602
Open AccessChirality‐Induced Hydroxyapatite Manipulates Enantioselective Bone‐Implant Interactions Toward Ameliorative Osteoporotic Osseointegration
Inspired by the fundamental attribute of chirality in nature, chiral‐engineered biomaterials now represent a groundbreaking frontier in biomedical fields. However, the integration of chirality within inorganic materials remains a critical challenge and developments of chirality‐induced bionic bone implants are still in infancy. In this view, novel chiral hydroxyapatite (CHA) coated Ti alloys are successfully synthesized by a sophisticated chiral molecule‐induced self‐assembly method for the first time. The obtained samples are characterized by stereospecific L‐/D‐/Rac‐chiral hierarchical morphology, nanotopography rough surfaces, improved hydrophilicity, and bioactivity. Following implantation into rat femoral condyle defects, the distinct stereospecific chiral hierarchical structures exhibit highly enantioselective bone‐implants interactions, wherein the left‐handed chirality of L‐CHA strongly promotes osteoporotic osseointegration and vice versa for right‐handed chirality of D‐CHA. Consistently, in vitro assays further validate the superior enantiomer‐dependent osteoporotic osseointegration ability of L‐CHA, mainly by manipulating desired immunomodulation coupled with enhanced neurogenesis, angiogenesis, and osteogenesis. Moreover, as analyzed by transcriptomic RNA‐seq, a new discovery of down‐regulated IL‐17 signaling pathway is considered predominately responsible for the desired immunomodulation ability of L‐CHA. These results provide new insights into biological multifunctionality and mechanism underlying L‐chirality's roles for bone healing, thus may inspiring developments of new generation of chiral biomaterials.
- 19 April 2022
- Published by IOP Publishing in Biomedical Materials
- Vol. 17 (3) , 039501
Corrigendum: Osteogenesis effects of strontium-substituted hydroxyapatite coatings on true bone ceramic surfaces in vitro and in vivo (2018 Biomed. Mater. 13 015018)
- 19 April 2022
- Published by IOP Publishing in Biomedical Materials
- Vol. 17 (3) , 039501
Corrigendum: Osteogenesis effects of strontium-substituted hydroxyapatite coatings on true bone ceramic surfaces in vitro and in vivo (2018 Biomed. Mater. 13 015018)
- 2 February 2022
- Published by IOP Publishing in Biomedical Materials
- Vol. 17 (2) , 025008
Biomimetic porous scaffolds containing decellularized small intestinal submucosa and Sr 2+ /Fe 3+ co-doped hydroxyapatite accelerate angiogenesis/osteogenesis for bone regeneration
The design of bone scaffolds is predominately aimed to well reproduce the natural bony environment by imitating the architecture/composition of host bone. Such biomimetic biomaterials are gaining increasing attention and acknowledged quite promising for bone tissue engineering. Herein, novel biomimetic bone scaffolds containing decellularized small intestinal submucosa matrix (SIS-ECM) and Sr 2+ /Fe 3+ co-doped hydroxyapatite (SrFeHA) are fabricated for the first time by the sophisticated self-assembled mineralization procedure, followed by cross-linking and lyophilization post-treatments. The results indicate the constructed SIS/SrFeHA scaffolds are characterized by highly porous structures, rough microsurface and improved mechanical strength, as well as efficient releasing of bioactive Sr 2+ /Fe 3+ and ECM components. These favorable physico-chemical properties endow SIS/SrFeHA scaffolds with an architectural/componential biomimetic bony environment which appears to be highly beneficial for inducing angiogenesis/osteogenesis both in vitro and in vivo . In particular, the cellular functionality and bioactivity of endotheliocytes/osteoblasts are significantly enhanced by SIS/SrFeHA scaffolds, and the cranial defects model further verifies the potent ability of SIS/SrFeHA to accelerate in vivo vascularization and bone regeneration following implantation. In this view these results highlight the considerable angiogenesis/osteogenesis potential of biomimetic porous SIS/SrFeHA scaffolds for inducing bone regeneration and thus may afford a new promising alternative for bone tissue engineering.
- 2 February 2022
- Published by IOP Publishing in Biomedical Materials
- Vol. 17 (2) , 025008
Biomimetic porous scaffolds containing decellularized small intestinal submucosa and Sr 2+ /Fe 3+ co-doped hydroxyapatite accelerate angiogenesis/osteogenesis for bone regeneration
The design of bone scaffolds is predominately aimed to well reproduce the natural bony environment by imitating the architecture/composition of host bone. Such biomimetic biomaterials are gaining increasing attention and acknowledged quite promising for bone tissue engineering. Herein, novel biomimetic bone scaffolds containing decellularized small intestinal submucosa matrix (SIS-ECM) and Sr 2+ /Fe 3+ co-doped hydroxyapatite (SrFeHA) are fabricated for the first time by the sophisticated self-assembled mineralization procedure, followed by cross-linking and lyophilization post-treatments. The results indicate the constructed SIS/SrFeHA scaffolds are characterized by highly porous structures, rough microsurface and improved mechanical strength, as well as efficient releasing of bioactive Sr 2+ /Fe 3+ and ECM components. These favorable physico-chemical properties endow SIS/SrFeHA scaffolds with an architectural/componential biomimetic bony environment which appears to be highly beneficial for inducing angiogenesis/osteogenesis both in vitro and in vivo . In particular, the cellular functionality and bioactivity of endotheliocytes/osteoblasts are significantly enhanced by SIS/SrFeHA scaffolds, and the cranial defects model further verifies the potent ability of SIS/SrFeHA to accelerate in vivo vascularization and bone regeneration following implantation. In this view these results highlight the considerable angiogenesis/osteogenesis potential of biomimetic porous SIS/SrFeHA scaffolds for inducing bone regeneration and thus may afford a new promising alternative for bone tissue engineering.
- 13 October 2021
- Published by IOP Publishing in Biofabrication
- Vol. 14 (1) , 019501
Corrigendum: Bioactive Sr 2+ /Fe 3+ co-substituted hydroxyapatite in cryogenically 3D printed porous scaffolds for bone tissue engineering (2021 Biofabrication 13 035007)
- 13 October 2021
- Published by IOP Publishing in Biofabrication
- Vol. 14 (1) , 019501
Corrigendum: Bioactive Sr 2+ /Fe 3+ co-substituted hydroxyapatite in cryogenically 3D printed porous scaffolds for bone tissue engineering (2021 Biofabrication 13 035007)